Invest
Induce Biologics Inc.
Invest PDF Print E-mail

Investment Opportunities: Induce Biologics has raised $11.4 million to date for the proof-of-priniciple work, manufacturing process development, and initial preclinical development.  Induce is now entering a significant phase of product development and hence provides a timely investment opportunity. Induce is currently seeking to raise a minimum of CAN$3 million to complete the GLP biocompatibility and toxicity testing needed to advance URIST™ to its first-in-human clinical trial, which is projected to begin in 2016, followed by CAN$6 million to complete the clinical trial.

 

For more information, please contact:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
416-599-2424

 

News

Follow InduceBio on Twitter and get all the updates regarding our latest activities, products, and future plans.

Follow Us on Twitter